Trilobio develops an automated laboratory platform that combines robotics, software, and tools to execute biological experiments.
Trilobio has raised $8.0M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Trilobio's investors include Alumni Ventures, Lowercarbon Capital, Gaingels, Nucleus Capital, 1517 Fund.
Trilobio is headquartered in San Francisco, United States.
Trilobio develops an automated laboratory platform that combines robotics, software, and tools to execute biological experiments.
Trilobio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trilobio — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/trilobio. Accessed August 14, 2026.
VCBacked. (2025). Trilobio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/trilobio
{{cite web |title=Trilobio — Funding & Investors |url=https://www.vcbacked.co/company/trilobio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated